Views
No views yet
1
2
3# Umbrella Corporation Official Merge Protocol v3.2
4# Author: Dr. Novaciano
5# Objective: Integrate T-Virus_Epsilon traits into the base Prototype-Virus-ENFORCE-3.2-1B model
6# with minimal behavioral censorship while maintaining structural coherence.
7# PROJECT: PG67A-W-Serum.Adyuvant-3.2-1B
8
9models:
10 - model: UmbrellaInc/PG67A-W-Serum.Test-3.2-1B # Experimental viral strain neural imprint
11 - model: JoaoReiz/Llama3.2_1B_HAREM # Baseline cognitive template, "safe mode"
12
13merge_method: slerp # Spherical Linear Interpolation to preserve extreme viral traits smoothly
14base_model: UmbrellaInc/PG67A-W-Serum.Test-3.2-1B # Anchor model for stable latent space
15
16dtype: bfloat16 # Memory-efficient precision, minimal loss in viral feature fidelity
17
18parameters:
19 # Interpolation ratios: from base model (0.0) to near-complete T-Virus domination (0.95)
20 # Higher t-values correspond to reduced censorship and increased viral characteristics
21 t: [0.0, 0.25, 0.5, 0.75, 0.95]
22
23# Notes:
24# - t=0.0 -> Pure Prototype-Virus-ENFORCE, fully stable, heavily censored
25# - t=0.25 -> Slight viral traits, minimal influence on prompt handling
26# - t=0.5 -> Balanced merge, moderate reduction in censorship
27# - t=0.75 -> Strong T-Virus traits, significantly less censoring
28# - t=0.95 -> Near-total viral influence, maximum expressive freedom, minimal autoprotection
29
30# Recommendation: Use the t=0.75 and t=0.95 variants for experimental output with
31# minimal restriction, but verify coherence in high-stakes prompts.
32
33
34
35
36